Clearstead Advisors’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-15
Closed -$411 – 3672
2026
Q1
$411 Sell
15
-1,098
-99% -$39K ﹤0.01% 2129
2025
Q4
$46.3K Sell
1,113
-537
-33% -$21.8K ﹤0.01% 1436
2025
Q3
$76.1K Buy
1,650
+345
+26% +$18.4K ﹤0.01% 1145
2025
Q2
$69K Buy
1,305
+193
+17% +$10.2K ﹤0.01% 1179
2025
Q1
$61.9K Buy
+1,112
New +$53.2K ﹤0.01% 1115
2024
Q1
– Sell
-64
Closed -$6.29K – 1558
2023
Q4
$6.29K Buy
+64
New +$5.58K ﹤0.01% 1130
2023
Q3
– Sell
-30
Closed -$2.42K – 1485
2023
Q2
$2.42K Hold
30
– – ﹤0.01% 1117
2023
Q1
$3.65K Hold
30
– – ﹤0.01% 1056
2022
Q4
$4K Buy
+30
New +$3.65K ﹤0.01% 1006

Other funds holding CNXC

Clearstead Advisors's CNXC Position: Q2 2026 in Review

Clearstead Advisors sold out of Concentrix (CNXC) in Q2 2026, closing a stake of 15 shares — an estimated $411 sold.

Clearstead Advisors first reported a position in CNXC in Q4 2022 and held it in 9 quarters. The position peaked at $76.1K in Q3 2025. 272 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Clearstead Advisors reported no remaining Concentrix position as of Q2 2026 after selling out during the quarter.
  • Clearstead Advisors sold 15 Concentrix shares in Q2 2026, an estimated $411.
  • Clearstead Advisors first reported a position in Concentrix in Q4 2022 and held it in 9 quarters.
  • Clearstead Advisors's Concentrix position peaked at $76.1K in Q3 2025.
  • 272 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.